7US-16503-34948
4 vaccinations
6 coded responses
38 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 430 / OH
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-19
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 21, dose 2MedDRA: Dyspnoea, Pregnancy, Sinus tachycardia, Tachycardia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening tachycardia and shortness of breath with advancing pregnancy and baseline sinus tachycardia.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
-
2021-05-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-07-27
Survey response — 6 months, dose 2MedDRA: Drug hypersensitivity, Eye pruritus, Ocular hyperaemia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Red itchy eyes due to being back on dupixent.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-27
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-28
-
2021-10-30
Dose 3 — Pfizer-BioNTech
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Abdominal pain lower — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Right lower quadrant abdominal painMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-28
- 2022-02-03
-
2022-10-14
Dose 4 — Pfizer-BioNTech
-
2022-10-16
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-18
- 2022-10-19
- 2022-10-20
-
2022-10-21
Health check-in — day 7, dose 4Feeling: Poor · Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-29
-
2022-11-04
Survey response — day 21, dose 4MedDRA: Abdominal pain — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Abdominal pain has become daily and more painful.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Report sent to call center — day 21, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-11
-
2022-11-18
Survey response — day 35, dose 4MedDRA: Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Viral syndromeMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
-
2023-01-13
Survey response — 3 months, dose 4MedDRA: Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-10-30 | Pfizer-BioNTech | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-16 | Successful 2021-05-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2021-07-27 | Successful 2022-11-07 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-01-26 | Successful 2022-11-07 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-11-04 | Successful 2022-11-07 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4 — day 21, dose 2
Symptoms: Worsening tachycardia and shortness of breath with advancing pregnancy and baseline sinus tachycardia.
Release 9 — 6 months, dose 2
Symptoms: Red itchy eyes due to being back on dupixent.
Release 11 — 12 months, dose 2
Symptoms: Right lower quadrant abdominal pain
Release 12 — day 21, dose 4
Symptoms: Abdominal pain has become daily and more painful.
Release 12 — day 35, dose 4
Symptoms: Viral syndrome
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Abdominal pain lower | · | · | ✓ |
| SD | Drug hypersensitivity | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Eye pruritus | ✓ | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Ocular hyperaemia | ✓ | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Sinus tachycardia | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release